MyAverix Finance
HK · Healthcare
Cutia Therapeutics (2487)
Biotechnology
Cutia Therapeutics (2487) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $1.48B, P/E ratio is 18.00, net margin is -101.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2487
Cutia Therapeutics (2487) — FAQ
What is Cutia Therapeutics's market cap?
Cutia Therapeutics (2487) has a reported market cap of $1.48B (data as of 2026-05-21).
What is 2487's P/E ratio?
The price-to-earnings (P/E) ratio for Cutia Therapeutics (2487) is 18.00 (data as of 2026-05-21).
Does Cutia Therapeutics pay a dividend?
Dividend yield is not available in the current snapshot for Cutia Therapeutics (2487). Check the MyAverix Finance app for the latest dividend data.
What sector is Cutia Therapeutics in?
Cutia Therapeutics (2487) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2487 listed on?
2487 is listed on HK.
What is Cutia Therapeutics's net margin?
Cutia Therapeutics (2487) reports a net margin of -101.2% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.